| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 451,900 | 455,400 | 452,900 | 446,600 | | Cost of Revenue | 190,300 | 192,400 | 189,000 | 181,300 | | | Gross Profit | 261,600 | 263,000 | 263,900 | 265,300 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 115,700 | 116,700 | 123,000 | 111,100 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 39,600 | 39,100 | 38,200 | 38,100 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 106,300 | 107,200 | 102,700 | 116,100 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 200 | 3,100 | 2,400 | 3,500 | | Earnings Before Interest And Taxes | 106,500 | 110,300 | 105,100 | 118,400 | | Interest Expense | 14,100 | 14,500 | 14,300 | 17,400 | | Income Before Tax | 92,400 | 95,800 | 90,800 | 101,000 | | Income Tax Expense | 31,000 | 34,700 | 34,700 | 37,000 | | Minority Interest |
-
|
-
|
-
| (1,200) | | | | Net Income From Continuing Ops | 61,400 | 61,100 | 56,100 | 64,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 61,400 | 61,100 | 56,100 | 64,000 | | Preferred Stock And Other Adjustments | (1,700) | (1,500) | (1,700) |
-
| | | Net Income Applicable To Common Shares | $59,700 | $59,600 | $54,400 | $64,000 |
|
0.29% Nasdaq 
Income Statement
